Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase

Stevan Pecic, Shi Xian Deng, Christophe Morisseau, Bruce D. Hammock, Donald W. Landry

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Inhibition of soluble epoxide hydrolase (sEH) has been proposed as a new pharmaceutical approach for treating hypertension and vascular inflammation. The most potent sEH inhibitors reported in literature to date are urea derivatives. However, these compounds have limited pharmacokinetic profiles. We investigated non-urea amide derivatives as sEH inhibitors and identified a potent human sEH inhibitor 14-34 having potency comparable to urea-based inhibitors.

Original languageEnglish (US)
Pages (from-to)601-605
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume22
Issue number1
DOIs
StatePublished - Jan 1 2012

Keywords

  • Anti-inflamatory
  • Hypertension
  • Non-urea inhibitors
  • sEH
  • Soluble epoxide hydrolase

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase'. Together they form a unique fingerprint.

  • Cite this